UMIN ID: UMIN000053154
Registered date:19/12/2023
Exploratory analysis of gut microbiome as a novel biomarker in patients with advanced thymic carcinoma on immunochemotherapy
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | thymic carcinoma |
| Date of first enrollment | 2024/01/04 |
| Target sample size | 35 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Whether the composition of the intestinal flora is a predictive factor |
|---|---|
| Secondary Outcome | Whether plasma biomarkers are predictive factors |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | none |
Related Information
| Primary Sponsor | Yusuke Okuma, National Cancer Center Hospital |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | pending |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Yusuke Okuma |
| Address | 5-1-1 Tsukiji, Chuo-ku, Tokyo Japan 104-0045 |
| Telephone | 03-3542-2511 |
| ncch2109_jimukyoku@is-pc.or.jp | |
| Affiliation | National Cancer Center Hospital Department of thoracic oncology |
| scientific contact | |
| Name | Yusuke Okuma |
| Address | 5-1-1 Tsukiji, Chuo-ku, Tokyo Japan |
| Telephone | 03-3542-2511 |
| ncch2109_jimukyoku@is-pc.or.jp | |
| Affiliation | National Cancer Center Hospital Department of thoracic oncology |